Cannabinoids and an Anti-inflammatory Diet for the Treatment of Neuropathic Pain After Spinal Cord Injury
Status:
Not yet recruiting
Trial end date:
2024-11-15
Target enrollment:
Participant gender:
Summary
Neuropathic pain is a common complication following spinal cord injury (SCI) that
significantly decreases quality of life. Treatment options are limited, and current
treatments can have significant side effects. Those with SCI have identified a need for
additional treatment options, particularly those that are not medications. Nabilone and an
anti-inflammatory diet are two treatments that may provide pain relief while being better
tolerated. This study will evaluate the benefits of these treatments for neuropathic pain
after SCI. Study participants will receive either an anti-inflammatory diet, nabilone or a
placebo (alone or in combination) for 12 weeks. It is expected that an anti-inflammatory diet
and nabilone will significantly decrease pain intensity and improve function. The combination
of both treatments together is expected to have a greater effect than each alone.